The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.60
Bid: 3.20
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.80 (25.00%)
Open: 3.60
High: 0.00
Low: 0.00
Prev. Close: 3.60
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: IG Design Gets CSS Boost; FireAngel In Virus Hit

Mon, 25th Jan 2021 16:17

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

IG Design Group PLC - consumer gift packaging business - For nine months to the end of December, revenue rises by 35% year-on-year to USD737 million, mainly due to the acquisition of CSS Industries Inc, first announced at the start of 2020. However, revenue excluding CSS is 9.2% lower. Due to the CSS addition, adjusted pretax profit for the nine-month period is higher than the year before. Looking ahead, IG Design's full year outlook remains in line with market expectations, as ongoing restrictions create continued uncertainty.

----------

FireAngel Safety Technology Group PLC - Coventry-based fire safety products firm - For 2020, sales expected to be down 12% year-on-year at GBP39.9 million from GBP45.5 million, due to the operational and market disruption caused by Covid-19, as well as delays on making progress in its Connected Homes strategy. However, noted strong recovery in second half. Looking ahead, company applies for increased Coronavirus Large Business Interruption Loan Scheme to provide further headroom and support revenue growth.

----------

Proteome Sciences PLC - drug development services provider - For 2020, expects posttax profit of GBP30,000, up from GBP20,000 the year before, on revenue that remains unchanged from GBP4.6 million the prior year. Proteome Services business revenue rises by 56% year-on-year to GBP1.5 million, while TMT and TMTpro sales accounts for GBP3.1 million. Looking ahead, company expects further growth in TMT and TMTpro.

----------

Anexo Group PLC - Liverpool-based legal services provider - For 2020, expects adjusted pretax profit to be in line with market expectations, as revenue growth beats company expectations as group remains operational throughout national lockdowns. In 2019, adjusted pretax profit was GBP23.1 million, on revenue of GBP78.5 million. Average number of vehicles on road in 2020 set to beat that of 2019, due to record numbers reached in second half of 2020.

----------

Inspiration Healthcare Group PLC - West Sussex-based medical technology company - For the year to the end of January, due to a strong performance from recent acquisition and ventilator designer SLE Ltd, expects earnings before interest, taxes, depreciation and amortisation of at least GBP4.9 million, on revenue of no less than GBP36.5 million. For the year before, Ebitda was GBP2.1 million, on revenue of GBP17.8 million.

----------

Sopheon PLC - enterprise software provider - Notes that final quarter of 2020 was the strongest for the group, despite the resurgence of Covid concerns. Total contract value of signed Software-as-a-Service business more than tripled year-on-year, while annual recurring revenue gross retention was at 91.5%, compared to 94.2% the year before. Looking ahead, company expects 2020 adjusted earnings before interest, taxes, depreciation and amortisation at USD5.6 million, down from USD6.4 million the year before. This is on revenue that is set to be around USD30 million, compared to USD30.3 million in 2019, and annual recurring revenue that is expected to rise to USD18 million from USD15.9 million. For 2021, ARR visibility is at USD22 million

----------

Filta Group Holdings PLC - commercial kitchen cleaning services provider - In 2020, delivers a much stronger performance in the second half, as customer numbers rise during the summer period. In the US and UK, demand starts to pick up in the second half quicker than expected, due to the return of customers. Cash and cash equivalents position at year-end as at December 31 is GBP4.2 million, up 45% from GBP2.9 million.

----------

Distribution Finance Capital Holdings PLC - bank providing personal savings products - For 2020, raises around GBP145 million in deposits. As at December 31, the loan book reached GBP113 million, up 36% from GBP83 million in October. As at Friday last week, loan book now stands at GBP125 million.

----------

Yellow Cake PLC - Jersey-based uranium investor - As at December 31, net asset value per share is GBP2.44, down from GBP2.56 at the end of September. Value of uranium oxide in concentrates is USD279.5 million, marginally higher from USD277.2 million as at September 30.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Sep 2014 09:58

Proteome Unit Wins Alzheimer's Diagnostics Contract With Genting TauRx

Read more
8 Jul 2014 17:00

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Buys Shares

Read more
8 Jul 2014 11:22

REPEAT: UK MIDDAY BRIEFING: M&S Online Sales Slump On Website Move

Read more
8 Jul 2014 11:19

UK MIDDAY BRIEFING: M&S Sales Slump On Website Move

Read more
8 Jul 2014 10:42

UK WINNERS & LOSERS: Airline Stocks Nosedive On Air France-KLM Warning

Read more
8 Jul 2014 08:45

UPDATE 1-Study paves way for simple blood test to predict Alzheimer's

* Fatal brain-wasting disease has no effective treatments * Experts say drug failures may be due to late trials * Predictive test could find people before disease sets in * Shares in Proteome Sciences, involved in work, jump 12 pct (Adds Proteome Sciences stock move) By

Read more
8 Jul 2014 08:26

Proteome Sciences Publishes Study For Alzheimer's Blood Test

Read more
29 May 2014 10:22

Proteome Sciences Confident For Revenue Growth As Loss Narrows

LONDON (Alliance News) - Proteome Sciences PLC Thursday expressed confidence for continued fast revenue growth for the "forseeable future", as it posted a narrowed pretax loss for 2013, driven by strong sales of its Tandem Mass Tag reagents and growth in its biomarker assays. Proteome is en

Read more
27 Mar 2014 14:08

Proteome Says Study Using SysQuant Technology Demonstrates Its Potential

LONDON (Alliance News) - Proteome Sciences PLC said Thursday that a study using its SysQuant technology to address pancreatic cancer published in medical journal PLOS ONE demonstrated the potential of proteomics to improve the way that bespoke treatments can be made to match patients. Prote

Read more
28 Feb 2014 16:18

XP Power board members reduce holdings

XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t

Read more
24 Feb 2014 10:48

Proteome Sciences To Raise GBP5 Million In Share Placing

LONDON (Alliance News) - Proteome Sciences PLC said Monday it has placed 17.9 million new shares on the market to raise GBP5 million before expenses, with new and existing investors, which it will use for additional working capital. The protein biomarker company said the shares were placed

Read more
7 Feb 2014 10:06

Proteome edges ahead after flagging rise in revenue

Biotech group Proteome Sciences edged ahead after it revealed it expects revenue for 2013 to show "a significant increase" over 2012 thanks to strong performance across its core activities. The firm is an expert in biomarkers, or biological markers, that can help predict the likelihood of cancer r

Read more
7 Feb 2014 09:08

Proteome Sciences Says 2013 Revenues To Be Significantly Up

LONDON (Alliance News) - Shares in Proteome Sciences PLC rose in early trading Friday, after the protein biomarker company said revenue for 2013 will be significantly higher than the prior year, driven by a strong performance from all its core activities. Proteome is engaged in research an

Read more
4 Dec 2013 10:39

Proteome Sciences unveils sales delays, shares fall

Biotechnology group Proteome Sciences is facing sales delays that will push revenue from some deals into next year, hitting its shares. Proteome, which carries out research into protein and peptide biomarkers to treat neurological conditions and other illnesses such as cancer, said the timing and r

Read more
20 Nov 2013 10:55

Proteome Sciences Says Study Using Its Workflows Shows New Protein Biomarkers For Liver Cancer

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.